位置:首页 > 产品库 > SB-277011 hydrochloride
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
SB-277011 hydrochloride
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
SB-277011 hydrochloride图片
规格:98%
分子量:475.02
包装与价格:
包装价格(元)
5mg询价
10mg询价
50mg询价
100mg询价

SB-277011hydrochloride(SB-277011Ahydrochloride)是一种强效、选择性、口服生物利用度和脑透多巴胺D3受体(D3R)拮抗剂,其Ki值在啮齿动物和人D3R分别为10.7nM和11.2nM。SB-277011hydrochloride对D3受体比其他多巴胺受体表现出80-100倍的选择性,,对D3,D2,5-HT1B 和5-HT1D受体的 pKi值分别为8.0,6.0,<5.2和5.9。
货号:ajcx29676
CAS:215804-67-4
分子式:C28H31ClN4O
分子量:475.02
溶解度:DMSO: 50 mg/mL (105.26 mM); H2O: 16.67 mg/mL (35.09 mM)
纯度:98%
存储:Store at -20°C
库存:现货

Background:

SB-277011 hydrochloride (SB-277011A hydrochloride) is a potent, selective, orally bioavailable and brain penetrate dopamine D3 receptor (D3R) antagonist with Ki values of 10.7 nM and 11.2 nM at rodent and human D3R, respectively. SB-277011 hydrochloride displays 80- to 100-fold selectivity over other dopamine receptors with pKis of 8.0, 6.0,<5.2, and 5.9 for D3, D2, 5-HT1B, and 5-HT1D receptors, respectively[1][2].


SB-277011 hydrochloride has an excellent pharmacokinetic profile, exhibits oral bioavailability 43%, half-life:2.0 h, plasma clearance 19 mL/min/kg) and to be highly brain-penetrant (brain:blood ratio of 3.6:1), with a clean P450 profile in the rat[1].SB-277011 hydrochloride (SB 277011; 3 mg/kg, p.o.) completely reverses the effects of quinelorane in the nucleus accumbens, but does not reverse the effects of quinelorane in the striatum at 93 mg/kg in rats[1].SB-277011 (intraperitoneal injection; 12.5-25 mg/kg) significantly and dose-dependently reduces intravenous cocaine self-administration under both low fixed-ratio and progressive-ratio reinforcement conditions in rats. When it increases to 50 mg/kg, SB-277011 can significantly inhibit basal and cocaine-enhanced locomotion in rats[2].

[1]. Stemp G, et al. Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat. J Med Chem. 2000 May 4;43(9):1878-85. [2]. Rui Song, et al. YQA14: A Novel Dopamine D3 Receptor Antagonist That Inhibits Cocaine Self-Administration in Rats and Mice, but Not in D3 Receptor-Knockout Mice. Addict Biol

 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024